Rebate and up-front considerations arrangements — Deferred revenue recognized
Idexx Laboratories Rebate and up-front considerations arrangements — Deferred revenue recognized increased by 4.2% to $2.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.7%, from $2.80M to $2.50M. Over 2 years (FY 2023 to FY 2025), Rebate and up-front considerations arrangements — Deferred revenue recognized shows a downward trend with a -9.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher recognition indicates strong execution in fulfilling contractual obligations and a steady flow of revenue from existing customer agreements.
Detailed definition
This metric represents the portion of deferred revenue from rebate and up-front arrangements that has been successfully...
Peer comparison
Comparable to revenue recognition from contract liabilities reported by companies with complex multi-element sales arrangements.
idxx_segment_rebate_and_up_front_considerations_arrangements_deferred_revenue_recognizedHistorical Data
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.15M | $3.15M | $3.15M | $3.15M | $3.00M | $2.80M | $2.70M | $2.50M | $2.80M | $2.60M | $2.50M | $2.40M | $2.50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -4.8% | -6.7% | -3.6% | -7.4% | +12.0% | -7.1% | -3.8% | -4.0% | +4.2% |
| YoY Change | — | — | — | — | -4.8% | -11.1% | -14.3% | -20.6% | -6.7% | -7.1% | -7.4% | -4.0% | -10.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized?
- Idexx Laboratories (IDXX) reported rebate and up-front considerations arrangements — deferred revenue recognized of $2.50M in Q1 2026.
- How has Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized changed year-over-year?
- Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized decreased by 10.7% year-over-year, from $2.80M to $2.50M.
- What is the long-term trend for Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized?
- Over 2 years (2023 to 2025), Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue recognized has grown at a -9.6% compound annual growth rate (CAGR), from $12.60M to $10.30M.
- What does rebate and up-front considerations arrangements — deferred revenue recognized mean?
- The amount of previously deferred revenue from rebate and up-front arrangements that was earned during the current period.